Medicare Enrolled
Dr. Aalok Patel, M.D.
Cardiovascular Disease · Orlando, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Aalok Patel is a cardiovascular disease in Orlando, FL, with 15 years in practice. Based on federal Medicare data, Dr. Patel performed 20,538 Medicare services across 2,926 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $90,630 from 45 pharmaceutical and/or device companies across 231 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice▲ Top 1% volume in FL$ $90,630 industry payments
Medicare Practice Summary
Medicare Utilization ↗20,538
Medicare services
Top 1% in FL for cardiovascular disease
2,926
Unique beneficiaries
$129
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,369 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 15,878 | $0 | $1 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 678 | $9 | $23 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 422 | $134 | $322 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 311 | $38 | $98 |
| Office visit, established patient (30-39 min) | 286 | $94 | $191 |
| Electrocardiogram (EKG), 12-lead | 283 | $11 | $36 |
| Hospital follow-up visit, moderate complexity | 223 | $62 | $146 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 181 | $724 | $2,632 |
| Initial hospital admission, high complexity | 137 | $134 | $411 |
| Regadenoson injection (Lexiscan) for heart stress test | 132 | $48 | $108 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 120 | $691 | $3,179 |
| Ultrasonic guidance for blood vessel access | 116 | $30 | $100 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 112 | $661 | $3,361 |
| EKG interpretation and report | 111 | $6 | $35 |
| Review by radiologist of arm or leg artery image | 100 | $117 | $750 |
| Review by radiologist of abdominal aorta image | 94 | $99 | $486 |
| Removal of plaque and insertion of stents in arteries of leg | 86 | $8,022 | $22,635 |
| Review by radiologist of both arms or legs arteries image | 75 | $126 | $759 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 71 | $458 | $2,165 |
| Insertion of tube into vein, second order branch | 65 | $350 | $1,494 |
| Insertion of stent in vein with review by radiologist, initial vein | 65 | $2,624 | $7,285 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 65 | $313 | $802 |
| Removal of plaque in artery of leg, initial vessel | 62 | $6,166 | $18,691 |
| Echocardiogram, transthoracic | 52 | $138 | $295 |
| Removal of plaque in artery of leg, each additional vessel | 48 | $810 | $2,294 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 48 | $102 | $350 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 47 | $53 | $106 |
| Cardiac catheterization | 44 | $588 | $2,437 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 44 | $87 | $175 |
| Removal of plaque and insertion of stents in artery of leg, initial vessel | 43 | $8,933 | $20,233 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 38 | $91 | $375 |
| Review by radiologist of abdominal artery image | 34 | $134 | $500 |
| Review by radiologist of major lower body vein image | 33 | $88 | $628 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 33 | $1,998 | $5,508 |
| Nuclear medicine study of heart muscle blood flow by pet | 33 | $135 | $266 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 32 | $132 | $280 |
| Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist | 30 | $626 | $2,826 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 30 | $88 | $432 |
| Removal of plaque in arteries of leg | 28 | $5,465 | $17,963 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 25 | $347 | $1,979 |
| Insertion of stent in groin artery, initial vessel | 24 | $1,725 | $7,041 |
| Hospital follow-up visit, high complexity | 24 | $94 | $213 |
| Ultrasound of both sides of head and neck blood flow | 19 | $141 | $297 |
| Insertion of tube into vena cava | 18 | $208 | $1,391 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 18 | $1,723 | $2,500 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 18 | $820 | $1,672 |
| Ultrasound study of arm and leg arteries | 17 | $54 | $261 |
| Injection for x-ray imaging procedure into vein of arm or leg | 16 | $98 | $654 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 15 | $330 | $664 |
| Insertion of stent in artery (except lower extremity, chest, heart, neck and brain) with review by radiologist, initial artery | 14 | $1,958 | $8,000 |
| Ultrasound of leg arteries or artery grafts | 14 | $170 | $370 |
| New patient office visit (45-59 min) | 14 | $125 | $253 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $46 | $110 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
82.2% medium
16.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$90,630
Total received (2018-2024)
Avg $12,947/year across 7 years
Top 5% in FL for cardiovascular disease
45
Companies
231
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$77,328 (85.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,585 (12.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,717 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$49,671
2023$31,284
2022$514
2021$1,137
2020$343
2019$1,100
2018$6,581
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$77,328
BIOTRONIK INC.
$1,816
Boston Scientific Corporation
$1,797
Medtronic Vascular, Inc.
$1,746
Abbott Laboratories
$1,655
AltaThera Pharmaceuticals LLC
$1,636
ABIOMED
$760
Boehringer Ingelheim Pharmaceuticals, Inc.
$495
Kestra Medical Technology Services, Inc.
$485
AstraZeneca Pharmaceuticals LP
$397
Edwards Lifesciences Corporation
$296
Cook Medical LLC
$267
Cardiovascular Systems Inc.
$219
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$211
Janssen Pharmaceuticals, Inc
$176
Philips Electronics North America Corporation
$169
Novo Nordisk Inc
$155
EKOS Corporation
$107
Amgen Inc.
$103
Ra Medical Systems, Inc.
$90
Novartis Pharmaceuticals Corporation
$86
Tactile Systems Technology Inc
$68
Merck Sharp & Dohme LLC
$53
PFIZER INC.
$51
W. L. Gore & Associates, Inc.
$49
E.R. Squibb & Sons, L.L.C.
$47
Chiesi USA, Inc.
$35
Terumo Medical Corporation
$30
Alnylam Pharmaceuticals Inc.
$29
Kiniksa Pharmaceuticals International, plc
$27
Impulse Dynamics (USA) Inc.
$26
SANOFI-AVENTIS U.S. LLC
$20
Alexion Pharmaceuticals, Inc.
$19
Esperion Therapeutics, Inc.
$18
Bard Peripheral Vascular, Inc.
$17
Inari Medical, Inc.
$16
Actelion Pharmaceuticals US, Inc.
$16
Amarin Pharma Inc.
$16
Cook Incorporated
$16
VivaQuant Inc, dba Rhythm Express
$15
iRhythm Technologies, Inc.
$15
Organogenesis Inc.
$14
ACIST MEDICAL SYSTEMS, INC.
$13
Gilead Sciences, Inc.
$12
Elutia, Inc.
$12
Top 3 companies account for 89.3% of total payments
Associated products mentioned in payments ›
AFFINITY · AMPLATZER · AVEIR · AZUR · Advisor Catheter · Arcalyst · Assure WCD · Assurity Pacemaker · Astron; Pulsar; AstronPulsar · Auryon Atherectomy Catheter 1.5 mm OTW · Auryon Laser System 100-120 Vac · BELSOMRA · BRILINTA · CAMZYOS · CARDIOFORM Septal Occluder · COOK MEDICAL IAA · COOK MEDICAL ZILVER PTX · CVX-300 · CareLink · CoreValve Evolut · Coronary Orbital Atherectomy System · DABRA · ECM Patch · EKOSONIC · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FLOWTRIEVER CATHETER · Flexitouch Plus · Fluency Endovascular Stent Graft · Fortify Assura · GENERAL - THERAPIES · GENERAL STENTS · HD-IVUS · HawkOne · HeartWare HVAD · IGT_D Peripheral · Impella · JARDIANCE · KENGREAL · LEQVIO · LifeVest · MULTAQ · Mitra Clip system · NEXLETOL · ONPATTRO · OPSUMIT · Optimizer · Optis Coronary Imaging System · Orsiro · Ozempic · PK Papyrus · PRO-Kinetic Energy · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Pouch · Pulsar · Repatha · Resolute · Rhythm Express · S · SOLIRIS · SYNERGY · Sentus · Sotalol Hydrochloride · VERQUVO · VYNDAMAX · Vascepa · WATCHMAN · XARELTO · Xience Alpine cornary stent system · Xience cornary stent systems · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 5% for cardiovascular disease in FL.
Equivalent to $441 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
172
Per 100K population
11.9
County median income
$77,011
Nearest hospital
UNIVERSITY BEHAVIORAL CENTER
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (mixed engagement, top 5%), with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Patel performed 15,878 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $90,630 from 45 companies across 231 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other cardiovascular diseases in Orlando?
Dr. Patel's average Medicare payment per service is $129. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Orlando
Browse cardiovascular diseases in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc..
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology